"Our vaccine has been approved in 40 countries." New vaccine offers hope in fight against disease that threatens half of ...

Takeda (NYSE:TAK) (4502.T) said on Monday that the European Commission approved Pfizer (NYSE:PFE) and the company's antibody-drug conjugate, Adcetrix, in combination with a chemotherapy regimen in ...

This is the web version of STAT’s special newslette r from the annual meeting of the American Society of Oncology. For more ...

US drugmaker Protagonist Therapeutics (Nasdaq: PTGX) and Japan’s Takeda Pharma (TYO:4502) announced detailed results from the ...

1, Polly Mack, 290.28. 2, Julia Lopez Ramirez, 286.77. 3, Auston Kim, 285.76. 4, Emily Kristine Pedersen, 283.34. 5, Weiwei Zhang, 281.13. 6, Maude-Aimee Leblanc, 278.68. 7, Bailey Tardy, 278.42. 8, ...

NEWARK, Calif. & OSAKA, Japan & CAMBRIDGE, Mass., June 01, 2025--(BUSINESS WIRE)--Protagonist Therapeutics, Inc. ("Protagonist") (NASDAQ:PTGX) and Takeda (TSE:4502 ...

Japanese rookie Rio Takeda finished tied for second at the U.S. Women's Open on Sunday as overnight leader Maja Stark of Sw ...

Defending champion Yuka Saso's bid for a third U.S. Open title in five seasons got off to a rocky start with a 2-over-par 74.

Takeda (TSE:4502/NYSE:TAK) today announced that applications are now open for its Innovators in Science Award. This prestigious global award, originally launched in 2016, celebrates groundbreaking ...

We are pleased to partner with Takeda as we continue to advance rusfertide to potentially transform the standard of care in PV patients around the world.” “These promising pivotal data ...